GDRX - Company ID 0001809519
GoodRx Holdings, Inc. trades as GDRX and has a market capitalization of $1.01 B, making it the #2620 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $796.85M, up 0.6% from the prior year and net income of $30.40M. This page tracks GoodRx Holdings, Inc. through 547 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-05-29
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 7 fiscal years GoodRx Holdings, Inc.'s revenue grew from $249.52M to $796.85M, a compound annual growth rate of 18.0%. Net profit margin compressed from 17.6% to 3.8% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider sale notice | 144 | 2026-05-13 |
| Insider trade | 4 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| New insider ownership | 3 | 2026-05-01 |
| Annual report to shareholders | ARS | 2026-04-29 |
GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs - GoodRx
GoodRx Reports First Quarter 2026 Results - GoodRx
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients - GoodRx
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call - GoodRx
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price - GoodRx
The largest companies sharing GoodRx Holdings, Inc.'s SEC industry classification (services-computer processing & data preparation).
GoodRx Holdings, Inc. (GDRX) has a market capitalization of $1.01 B as of 2026-05-29, ranking #2620 among US-listed companies.
GoodRx Holdings, Inc. reported revenue of $796.85M for fiscal year 2025, an increase of 0.6% year over year.
Yes. GoodRx Holdings, Inc. reported net income of $30.40M in its latest fiscal year.